期刊文献+

胱抑素C联合eGFR-MDRD诊断早期DN的研究 被引量:3

Studies of Cystatin C joint eGFR-MDRD for diagnosis of early DN
下载PDF
导出
摘要 目的:比较分析胱抑素C(Cys C)、BUN、Scr、e GFR-MDRD和e GFR-cys等检测指标在诊断早期DN中的应用价值。方法:随机收集2012年1月至2014年10月本院收治的2型糖尿病(Type 2 diabetes mellitus,T2DM)患者214例和来本院体检的100名健康人,并根据尿蛋白排泄率分为单纯的T2DM组和糖尿病组(DN组),收集患者的血肌酐(Scr)、尿素氮(BUN)、血清胱抑素C(Cys C)等检测指标,并采用简化的MDRD公式根据Scr估算出e GFR(e GFR-MDRD),而Cys C则使用CHINAcys方程计算得出e GFR(e GFR-cys),对这些检测指标做统计学分析。结果:DN组和对照组相比BUN、Scr、Cys C、e GFRMDRD和e GFR-cys都有显著性变化,其中BUN、Scr和Cys C均显著高于对照组;e GFR-MDRD和e GFR-cys与对照组相比显著较低,5个检测指标均P<0.05;五个常用的检测指标ROS曲线面积都大于0.5,且P<0.05;单个检测指标中Cys C的检测指标最高能够达到80.38,其次是BUN和e GFR-MDRD;而联合检测中e GFR-MDRD+Cys C的灵敏度和约登指数远远高于e GFRMDRD+e GFR-cys和其他单项检测指标。结论:e GFR-MDRD结合Cys C指标的诊断对早期DN筛查是一种有效、可行且准确度较高的方法。 Objective:Comparative analysis detection indexes such as [ inhibition C ( CysC ) , BUN, Scr, eGFR-MDRD and eGFR-cys] of application value in the diagnosis of early DN.Methods: Randomly collected the Type 2 diabetes ( Type 2 diabetes mellitus,T2DM)214 cases patients to our hospital check-up and 100 healthy people from January 2012 to October 2014,and according to the urinary albumin excretion rate could divided into pure T2DM group and diabetes group(DN group),collected the patient′s serum creatinine( Scr) ,urea nitrogen( BUN) ,serum[ inhibition( Cys C) detection indexes such as C,and USES the simplified MDRD formula according to the Scr estimate the eGFR(eGFR-MDRD),while using CysC CHINAcys equation calculated eGFR,eGFR-Cys],make statistical analysis for these measurements.Results: DN group compared with control group ,the BUN,Scr,CysC,eGFR-MDRD and eGFR-cys had significant changes,including BUN,Scr and CysC was significantly higher than control group;EGFR-MDRD and eGFR-cys significantly lower compared with control group,5 testing indexes,P〈0.05.Five commonly used detection index curve of ROS area was greater than 0.5,and P〈0.05.A single detection index of CysC indicators could reach 80.38,the highest followed by BUN and eGFR-MDRD;And joint detection of eGFR MDRD+Cys C much higher sensitivity and an index of eGFR-MDRD+eGFR-Cys and other individual detection index.Conclusion:eGFR-MDRD CysC indicator in the diagnosis of early DN screening is an effective,feasible, and the method of high accuracy.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2015年第10期1394-1396,1399,共4页 Chinese Journal of Immunology
关键词 糖尿病肾病 早期诊断 胱抑素C eGFR-MDRD DN Cystatin C Early diagnosis eGFR-MDRD
  • 相关文献

参考文献12

  • 1中华医学会糖尿病学分会.中国2 型糖尿病防治指南(2010 年版)[M].北京:北京大学医学出版社,2011:13.
  • 2焦文举,袁文明,赵占正.不同胱抑素C方程与简化MDRD方程在评估慢性肾脏病患者GFR中的关系[J].实用医学杂志,2014,30(3):434-437. 被引量:8
  • 3Pavkov ME, Knowler WC, Hanson RL, et al. Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy[ J]. Ame J Kidney Dis,2013,62( 1 ) :33-41.
  • 4Jeon YK,Kim MR,Huh JE,et al. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes [ J ]. J Korean Med Sci,2011,26(2) :258-263.
  • 5Papadopoulou-Marketou N, Skevaki C, Kosteria I, et al. NGAL and cystatin C:two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up [ J]. Hormones( Athens, Greece) ,2015,14( 2 ) : 1-9.
  • 6Kim SS,Song SH,Kim IJ,et al. Urinary cystatin C and tubular pro- teinuria predict progression of diabetic nephrepathy [ J ]. Diabetes Care,2013,36(3 ) :656-661.
  • 7Krolewski AS, Warram JH, Forsblom C, et al. Serum concentration of cystatin C and risk of end-stage renal disease in diabetes [ J ]. Diabetes Care,2012,35 ( 11 ) : 2311-2316.
  • 8Lewis EJ, Greene T, Spitalewiz S, et al. Pyridorin in type 2 diabetic nephropathy [ J]. J Ame Soe Nep ,2012,23 ( 1 ) :131-136.
  • 9Jeon YL,Kim MH,Lee WI,et al. Cystatin C as an early marker of diabetic nephropathy in patients with type 2 diabetes [ J ]. Clin Lab ,2012,59(11-12) : 1221-1229.
  • 10Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from Serum creatinine and cystatin C [ J ]. New Eng J Med,2012,367( 1 ) :20-29.

二级参考文献15

  • 1王海燕.肾脏病临床概览[M].北京:北京大学医学出版社,2010:40-47.
  • 2Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States [J]. JAMA, 2007,298( 17): 2038-2047.
  • 3Xu R, Zhang LX, Zhang PH, et al. Comparsion of the prevalence of chronic kidney disease among different ethnicities: Beijing CKD survery and American NHANES [J]. Nephrol Dial Transplant, 2009,24 (4) : 1220-1226.
  • 4Levey AS, Bosch JP, Levis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation [J]. Ann Intern Med, 1999,130(6): 461-470.
  • 5Rule AD, Bergstralh EJ, Slezak JM, et al. Glomerular filtration rate estimated by cystatin C among different clinical presentations [ J ]. Kidney Int, 2006,69 (2) : 399-405.
  • 6Macisaac RJ, Tsalamandris C, Thomas MC, et al. Estimating glomerular filtration rate in diabetes: a comparison of cystatin- C-and creatinine-based methods [J]. Diabetologia, 2006,49 (7) : 1686-1689.
  • 7Perkins BA, Nelson RG, Ostrander BE, et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study [J]. J Am Soc Nephrol, 2005,16(5) : 1404-1412.
  • 8Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD [J]. Am J Kidney Dis, 2008,51 (3) : 395-406.
  • 9Magdalena M, Mark JS, Lesley AS. Serum cystatin C as a marker of glomerular filtration rate [J]. Curr Opin Nephrol Hypertents, 2006,15(6) :610-616.
  • 10Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and impact on renal function measurement [J]. Kidney Int,2004,65(4):1416-1421.

共引文献70

同被引文献24

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部